Back to Results
First PageMeta Content
Drug addiction / Alcohol abuse / Drug rehabilitation / Pharmacology / Withdrawal syndromes / Benzodiazepine withdrawal syndrome / Naltrexone / Methadone / Benzodiazepine dependence / Chemistry / Addiction / Ethics


Document Date: 2011-07-02 03:15:53

Open Document

File Size: 755,35 KB

Share Result on Facebook

City

Gladesville / Sydney / /

Company

Cell Therapeutics Inc. / /

Event

Product Issues / Product Recall / FDA Phase / /

Facility

University of Melbourne / /

/

IndustryTerm

care protocol / detoxification services / /

MedicalCondition

alcohol withdrawal syndrome / difficult behaviour Seizures Delirium / withdrawal syndrome / respiratory disease Severe liver disease Hallucinations / Opioid withdrawal syndrome / /

Organization

University of Melbourne / Alcohol and Drug Service / Drug Treatment Policy Unit / NSW Drug and Alcohol Specialist Advisory Service / NSW Health Department / Working Party / Steering Committee / Victorian Department of Human Services / /

Person

Ian Webster / Ian W Webster / /

/

Position

AO Chair / Professor / /

Product

phase Opioid / scale / Protracted / Routine observations / Clinical Institute / alcohol / Seizures Concurrent anxiety / Benzodiazepine / 3.3 Patterns of use Incidental withdrawal Rebound Symptom re-emergence Withdrawal syndrome Managing / 56 56 57 Contents 3 Managing / Opioid / syndrome / Key areas / Opiate / Incidental / Opioid drug use Incidental / Managing opioid / Introduction Detoxification / Short opiate withdrawal scale Opioid / E1 / /

ProvinceOrState

Victoria / New South Wales / /

Region

South Wales / /

Technology

Supportive care protocol / /

SocialTag